fanasil, pyrimethamine drug combination: Clinical Trials

117 trials of fanasil, pyrimethamine drug combination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

88 completed, 15 unknown, 8 terminated, 2 active not recruiting. 44 Phase 3, 31 Not applicable, 25 Phase 4, 17 Phase 2, 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 344Completed 35, Terminated 4, Unknown 3, Active not recruiting 1, Withdrawn 1
Not applicable31Completed 24, Unknown 4, Terminated 2, Active not recruiting 1
Phase 425Completed 15, Unknown 6, Terminated 2, Not yet recruiting 1, Withdrawn 1
Phase 217Completed 14, Suspended 1, Terminated 1, Unknown 1
Phase 19Completed 6, Unknown 2, Suspended 1

Follow fanasil, pyrimethamine drug combination: new trials by email Literature Review of fanasil, pyrimethamine drug combination trials Research Report on fanasil, pyrimethamine drug combination

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perennial Malaria Chemoprevention in the Malaria Vaccine Era
Sulfadoxine pyrimethamine + Amodiaquine, Dihydroartemisinin Piperaquine, Dihydroartemisinin Piperaquine Placebo - Malaria, Falciparum
Phase 4Not yet recruitingStanford University12902026-09-012026-01-07
Parasite Clearance and Protection From Infection (PCPI) in Zambia
SP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals) - Malaria
Phase 3CompletedLondon School of Hygiene and Tropical Medicine6002024-07-242025-03-12
Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control
Sulphadoxine-pyrimethamine and Amodiaquine - Malaria, Soil Transmitted Helminths
Not applicableUnknownLondon School of Hygiene and Tropical Medicine12002024-05-272024-03-20
Eggs for Gut Health
Whole egg powder, Corn powder, Supercereal Plus - Moderate Acute Malnutrition, Stunting
Not applicableCompletedWashington University School of Medicine4612023-10-092025-02-06
Improving Cognition and Gestational Duration With Targeted Nutrition
M-RUSF+ (Maternal Ready-to-Use Supplementary Food + DHA/EPA/choline), M-RUSF (Maternal Ready-to-Use Supplementary Food), Azithromycin - Malnutrition in Pregnancy, Preterm Birth
Not applicableActive not recruitingWashington University School of Medicine16602023-08-182026-03-02
Perennial Malaria Chemoprevention (PMC) in Côte d'Ivoire
Sulfadoxine pyrimethamine - Malaria, Anemia
CompletedLondon School of Hygiene and Tropical Medicine13812023-08-112026-09-08
Perennial Malaria Chemoprevention (PMC) in Cameroon
Sulfadoxine pyrimethamine - Anemia, Malaria
CompletedLondon School of Hygiene and Tropical Medicine21382023-07-192026-09-08
Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso
Sulphadoxine-Pyrimethamine/Amodiaquine, Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM) - Malaria
Phase 3UnknownMalaria Consortium130002023-07-152023-11-22
Comparing Chemoprevention Drugs for School-based Malaria Control
Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine pyrimethamine - Malaria,Falciparum, Anemia in Children
Phase 4CompletedUniversity of Maryland, Baltimore6462023-02-132023-08-07
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
Dihydroartemisinin-Piperaquine (DP), Sulfadoxine pyrimethamine (SP) - Malaria, Malaria in Pregnancy
Phase 3Active not recruitingMenzies School of Health Research11722022-08-312025-06-06
Controlled Human Malaria Infection Transmission Model - Phase A
PfSPZ Challenge, Sulfadoxine-Pyrimethamine, Piperaquine - Malaria,Falciparum
Phase 1 / Phase 2SuspendedUniversity of Oxford442022-08-222024-05-23
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan
Sulfadoxine pyrimethamine, Amodiaquine - Malaria
Phase 3UnknownMalaria Consortium35752022-07-182024-03-25
Chemoprevention Efficacy Study in Burkina Faso
Sulfadoxine pyrimethamine, Amodiaquine - Malaria
Phase 4UnknownMalaria Consortium8002022-07-152023-11-01
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
Albendazole, Praziquantel, Amodiaquine - Malaria, Soil Transmitted Helminths
Not applicableUnknownLondon School of Hygiene and Tropical Medicine6002022-06-162022-07-14
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Uganda
Sulfadoxine pyrimethamine and amodiaquine, dihydroartemisinin-piperaquine - Malaria
Phase 4UnknownMalaria Consortium68052022-06-012023-11-01
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study
Chemopreventive Agent - SPAQ, Control Test - no drugs given - Malaria
Phase 4UnknownMalaria Consortium31562022-01-082023-11-02
Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali
Artemether-lumefantrine, Primaquine Phosphate, Sulphadoxine-pyrimethamine with amodiaquine - Malaria,Falciparum
Phase 2CompletedLondon School of Hygiene and Tropical Medicine802021-10-122022-01-18
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
Sulfadoxine pyrimethamine, Pyramax - Malaria in Pregnancy
Phase 3CompletedUniversity of Kinshasa2502021-05-062022-11-04
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
Sulfadoxine-pyrimethamine (SP), Dihydroartemisinin-piperaquine (DP) - Malaria
Phase 3CompletedGrant Dorsey, M.D, Ph.D.27572020-12-282025-11-06
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
IPTp-sulphadoxine-pyrimethamine plus metronidazole, IPTp-dihydroartemisinin-piperaquine plus metronidazole, IPTp-sulphadoxine-pyrimethamine - Pregnancy Malaria, Bacterial Vaginoses
Phase 3CompletedLondon School of Hygiene and Tropical Medicine54362019-12-152023-05-22

Showing 20 of 117. Sign in to see all of them.

Conditions studied

Malaria (87)  ·  Malaria, Falciparum (22)  ·  Anemia (13)  ·  HIV Infections (5)  ·  Malaria, Vivax (4)  ·  Birth Weight (3)  ·  HIV Seropositivity (3)  ·  Schistosomiasis (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Anemia, Sickle Cell (2)  ·  Growth Disorders (2)  ·  Premature Birth (2)  ·  AIDS-Related Opportunistic Infections (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Lymphoproliferative Syndrome (1)

Sponsors

London School of Hygiene and Tropical Medicine (33)  ·  Centers for Disease Control and Prevention (7)  ·  Institute of Tropical Medicine, Belgium (5)  ·  Malaria Consortium (5)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Hospital Clinic of Barcelona (4)  ·  Washington University School of Medicine (4)  ·  Pfizer (3)  ·  Radboud University Medical Center (3)  ·  University of California, San Francisco (3)  ·  University of Cape Town (3)  ·  University of Oxford (3)  ·  Albert Schweitzer Hospital (2)  ·  Grant Dorsey, M.D, Ph.D. (2)  ·  Liverpool School of Tropical Medicine (2)

Countries

Mozambique (11)  ·  Kenya (9)  ·  Malawi (9)  ·  Tanzania (9)  ·  Uganda (9)  ·  Burkina Faso (7)  ·  Mali (7)  ·  The Gambia (6)  ·  Ghana (5)  ·  Nigeria (5)  ·  Zambia (5)  ·  Gabon (4)  ·  Papua New Guinea (4)  ·  Senegal (4)  ·  Benin (3)

Top investigators

Brian Greenwood, MD (4)  ·  Mark J Manary, MD (4)  ·  Paul J Milligan, PhD (4)  ·  Badara Cisse, PhD (3)  ·  Brian Greenwood, FRCP, FRS (3)  ·  Clara Menendez, MD, PhD (3)  ·  Karen Barnes, MBChB (3)  ·  R Matthew Chico, MPH, PhD (3)  ·  Alassane Dicko, MD (2)  ·  Christine Manyando, MD (2)  ·  Daniel Chandramohan, MBBS, PhD (2)  ·  Frank Mosha, PhD (2)  ·  Ghulam Rahim Awab, MD (2)

Results publications

PMID 39324693, PMID 19558654, PMID 26917051, PMID 39243075, PMID 15155976, PMID 15330070, PMID 16195288, PMID 17046467, PMID 17093247, PMID 17519409, PMID 18000538, PMID 18008241, PMID 18008242, PMID 18074034, PMID 18213379, PMID 18398460, PMID 18419347, PMID 18651857, PMID 18752443, PMID 18828899, PMID 18831691, PMID 19098989, PMID 19238219, PMID 19469703, PMID 19707564, PMID 19765815, PMID 19784374, PMID 19789648, PMID 19848610, PMID 19954383, PMID 20194698, PMID 20195472, PMID 20209126, PMID 20368815, PMID 20574538, PMID 20574541, PMID 20808923, PMID 20976051, PMID 20976217, PMID 21199881, PMID 21203389, PMID 21214940, PMID 21443960, PMID 21569596, PMID 21767403, PMID 21864343, PMID 22073137, PMID 22198787, PMID 22303437, PMID 22412865

NIH funding

P01HD059454 (1), R01AI104702 (1)